Keith Martin

This user account status is Approved
Martin
Keith
United Kingdom

Vice President and President Elect of the World Glaucoma Association;

Academic Lead for Ophthalmology and Head of the Glaucoma Service at Cambridge University Hospitals NHS Foundation Trust;

Group Leader and Deputy Director, John van Geest Centre for Brain Repair, University of Cambridge;

Faculty Member, National Institute for Health Research;

Affiliate Principal Investigator, Cambridge Stem Cell Institute.

Medical and surgical management of complex glaucoma in adults and children.

Established the Glaucoma Research Laboratory at the University of Cambridge in 2005, aiming to develop new treatments for eye disease using stem cells, gene therapy and other approaches.


Sessions


Wednesday 11.45 am-12.45 pmPlenary 2

Game Changers in Glaucoma

Chair(s): Keith Martin (United Kingdom); Makoto Araie (Japan); Robert Weinreb (United States); Winifred Nolan (United Kingdom);

Wednesday 2.00 pm-3.00 pmRoom 212 & 213

General Assembly

Chair(s): TBA;

Wednesday 3.00 pm-4.30 pmPlenary 2

New frontiers in glaucoma

Chair(s): Janet Serle (United States); Peng Khaw (United Kingdom);

Thursday 12.15 pm-1.15 pmPlenary 2

ALLERGAN - Rethinking Decision-Making in Glaucoma Management

Chair(s): Keith Martin (United Kingdom); Michael Coote (Australia);

Thursday 1.45 pm-3.15 pmRoom 220

Spotlight on Glaucoma in Africa

Chair(s): Neeru Gupta (Canada); Eddie Kgao Legodi (South Africa); Keith Martin (United Kingdom);

  • 1.45-1.48
    Opening Remarks
    Neeru Gupta (Canada)
  • 1.48-1.56
    A Call to Action in Africa
    Eddie Kgao Legodi (South Africa)
  • 1.56-2.04
    The Magnitude and Burden of Glaucoma in Africa
    Nkiru Kizor-Akaraiwe (Nigeria)
  • 2.04-2.12
    Is Glaucomatous Disease Different in Africa? Unique Clinical characteristics
    Susie Williams (South Africa)
  • 2.12-2.20
    Challenges and Opportunities of Medical and Surgical Management
    Dan Kiage (Kenya)
  • 2.20-2.28
    The Role of Laser Surgery in Africa
    Tony Realini (United States)
  • 2.28-2.32
    My journey - reducing blindness from glaucoma in South Africa
    Philip Phatudi (South Africa)
  • 2.32-2.36
    My journey - reducing blindness from glaucoma in Cameroon
    Martin Tchouyo (Cameroon)
  • 2.36-2.40
    My journey reducing blindness from glaucoma in Nigeria
    Farouk Garba (Nigeria)
  • 2.40-3.15
    Panel/Audience Discussion

Friday 10.30 am-12.00 pmRoom 212 & 213

New Potions from the Hogwarts Cauldron for Treating Glaucoma

Chair(s): Leonard Levin (Canada); Viney Gupta (India); Francesca Cordeiro (United Kingdom);

Friday 1.45 pm-3.15 pmRoom 203 & 204

ANZGS Symposium - The Gillies Lecture, and A Showcase of Glaucoma Research from Australian and NewZealand Universities

Chair(s): Anne Brooks (Australia); Keith Martin (United Kingdom); Ivan Goldberg (Australia);

Contact

Please contact our Professional Congress Organizer MCI for all your WGC-2019 questions

MCI Amsterdam
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands
www.mci-group.com
wgc@mci-group.com